Enhancing Public Procurement Efficiency in Maldives
SUMMARY
Access to high quality, and affordable health-care services is critical to strengthening the Maldivian Universal Health Coverage Scheme. To ensure this while also drivingcost efficiencies for the Universal Health Coverage Scheme in Maldives, quality-assured bulk procurement of essential medicines has been identified as an important strategy to achieve economies of scale, resulting in cost- savings, and ultimately contributing towards attainment of the sustainability of the scheme.
UNDP’s Project Initiation Plan (PIP) with the Government of Maldives is aimed to lay the foundation for procurement of selected medicines at scale, with also a key component of providing technical assistance required to build the necessary supply chain management and logistical planning expertise within national systems and institutions.
BACKGROUND
The overall objective of the Project is to strengthen the long-term financial sustainability of the Maldives Universal Health Coverage Scheme — "Aasandha” .
UNDP’s assistance in procuring quality-assured medicines at scale is expected to streamline the delivery time and the costs. The potential savings and service efficiency from this project can be reallocated towards improving the quality of healthcare services in the Maldives, which can increase the coverage of existing social protection mechanisms and public health service delivery channels across the country, especially in the outer islands of Maldives through allocative efficiency.
The initiative links Maldives to global medicine supply chains through UNDP Global Long Term Agreement holders, ensuring broader and wider access to manufacturers and suppliers all over the world. The UNDP's procurement approach follows a stringent quality assurance process, and ensures high-quality health products from WHO-approved manufacturers, along with robust transparency and risk management practices.
For more information on UNDP Quality Assurance Process for Health Products see: https://popp.undp.org/policy-page/quality-assurance-health-products.
PROJECT OUTCOMES
- Enhancing cost efficiency in medicine procurement through bulk purchasing
- Providing technical advisory/capacity building on health financing, data management, public procurement and strengthening medicine legal framework
GEWE / GESI COMPONENT
Gender responsiveness will be mainstreamed throughout the project.
ACHIEVEMENTS
Based on needs identified and orders placed by the national partners, the medicines below have been procured through this project thus far.
PROCUREMENT DETAIL
Procured and Delivered
| Insulin Analogue long acting, Glargine, 100IU/ml, injectable solution |
| Insulin Analogue rapid, Aspart, 100IU/ml, injectable solution |
| Ceftriaxone, 1g powe |
| Diclofenac, 50mg |
| Meropenem trihydrate 1000 mg, |
| Vildagliptin, 50mg, |
| Vildagliptin + Metformin, 50mg + 1000mg |
| Carbamazepine, 100mg/5ml, oral solution |
| Carbamazepine, 200mg |
| Fluoxetine, 20mg |
Procured and Delivered
| Phenobarbital (sodium), 200mg/ml |
| Diazepam, 2mg |
| Ceftriaxone (sodium), 500mg |
| Amoxicillin/Clavulanic acid, 1000mg/200mg |
| Lorazepam, 1m |
| Indacaterol (maleate)/Glycopyrronium (bromide), 110mcg/50mcg |
| Carbamazepine, 200mg |
| Diclofenac (sodium), 50mg |
| Meropenem trihydrate 1000 mg |
| Insulin Analogue rapid, Aspart, 100IU/ml, injectable solution, 3ml |
| Insulin Analogue long acting, Glargine, 100IU/ml, injectable solution, 3ml |
Procured and Delivered
| Ceftriaxone (sodium), 500mg |
| Lidocaine HCl 2% injection 20 ml |
| Water for injection 10 ml |
Order in Progress
| Entecavir, 0.5mg |
Procured and Delivered
| Fenorfibrate Capsule 200 mg |
| Escitalopram Tablet 10 mg |
| Gabapentin Tablet 100 mg |
| Gabapentin Tablet 300 mg |
| Rivaroxaban Tablet 10 mg |
| Montelukast Chewable Tablet 5 mg |
| Insulin Glargine 100 IU |
| Itraconazole 100 mg |
Order in Progress
| Mycophenolate Mofetil 500mg |
| Prazosin 5mg |
| Oxcarbazepine 300mg |
| Insulin, aspart, 100 U/ml, solution for injection |
| piperacillin 4 g + tazobactam 500 mg |
| benzhexol HCl (trihexyphenidyl) 2 mg |
| Montelukast 10mg film-coated tablet |
| Cefuroxime 1.5g |
| Aspirin 75mg E/C |
| Azithromycin 500 mg |
| Mycophenolate Mofetil 500mg |
| Fluticasone Propionate Nasal Spray 50 mcg |
| Montelukast Tablet (IR) 10 mg |